Sinopharm Group Co., Ltd.
Underestimation
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| P/E |
10/10
|
6.22 | 31.52 | -80.28% | 3.31 | +87.63% |
| P/S |
|
0.0943 | 3.23 | -97.08% |
|
|
| P/BV |
|
0.4677 | 3.36 | -86.08% |
|
|
| P/FCF |
|
0.5695 | 21.22 | -97.32% |
|
|
| Ev/Ebitda |
|
2.34 | 9.93 | -76.45% |
|
|
| Ev/S |
|
0.111 | 1.88 | -94.11% |
|
|
| Ev/FCF |
|
4.47 | 19.91 | -77.58% |
|
|
| E/P |
|
1.07 | 1.47 | -27.12% |
|
|
Efficiency
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Ebitda margin |
1/10
|
4.75 | 24.35 | -80.5% | 5.07 | -6.26% |
| ROE |
|
12.14 | 13.11 | -7.43% |
|
|
| ROA |
|
2.36 | 6.09 | -61.25% |
|
|
| ROIC |
|
8.01 | 15.56 | -48.52% |
|
|
| ROS |
|
1.52 | 12.44 | -87.78% |
|
|
| ROCE |
|
19.86 | 14.35 | 38.43% |
|
|
Debt
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Debt/Ebitda |
6/10
|
2.48 | 6.21 | -60.03% | 2.48 | +0.058% |
| Nеt Debt/Ebitda |
|
0.3521 | -5.72 | -106.15% |
|
|
| Debt/Ratio |
|
0.1835 | 0.213 | -13.84% |
|
|
| Debt/Equity |
|
1.58 | 12.49 | -87.37% |
|
|
| Debt/Net Income |
|
7.77 | 15.07 | -48.42% |
|
|
Dividends
| Parameter | Grade | Value | Sector average | Difference with sector, % | Average for 5 years | Difference from average, % |
|---|---|---|---|---|---|---|
| Dividend yield |
10/10
|
4.53 | 1.76 | 157.17% | 9.47 | -52.16% |
| Number of years of dividend growth |
|
1 | 1.21 | -17.44% | ||
| DSI |
|
0.8571 | 0.7783 | 10.13% |
|
|
| Average dividend growth |
|
-93.37 | -269.81 | -65.39% |
|
|
| Average percentage for 5 years |
|
9.47 | 2.8 | 237.74% |
|
|
| Average percentage for payments |
|
31.71 | 246.95 | -87.16% |
|
|
| Difference from average difference in sector |
|
2.77 |
Growth impulse
| Parameter | Grade | Value | Sector average | Difference with sector, % | ||
|---|---|---|---|---|---|---|
| Growth impulse Revenue in 5 years |
6/10
|
40.28 | 132.71 | -69.65% | ||
| Growth impulse Ebitda in 5 years |
|
24.25 | 100.7 | -75.92% | ||
| Growth impulse Net Income in 5 years |
|
44.83 | 116.53 | -61.53% | ||
| Growth impulse FCF in 5 years |
|
-8.57 | 88.28 | -109.71% | ||
| Growth impulse EPS in 5 years |
|
837.34 | 217.84 | 284.38% |
IP Score
6.19/10
